Precigen (PGEN) insider exercises 143,678 RSUs into common stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PRECIGEN, INC. director and major shareholder Randal J. Kirk reported the vesting and exercise of 143,678 restricted stock units into an equal number of shares of common stock at an exercise price of $0.00 per share on March 13, 2026.
The shares are held indirectly through the R.J. Kirk Declaration of Trust, which now holds 81,781,816 shares of Precigen common stock. Additional Form 4 entries list indirect holdings in various trusts, LLCs and related entities that Mr. Kirk controls, with beneficial ownership disclaimed except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
143,678 shares exercised/converted
Mixed
17 txns
Insider
KIRK RANDAL J
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 143,678 | $0.00 | -- |
| Exercise | Common Stock | 143,678 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Indirect, by R.J. Kirk DOT);
Common Stock — 81,781,816 shares (Indirect, by. R.J. Kirk DOT)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one (1) share of issuer common stock. The restricted stock units were granted on March 13, 2025 and vested in their entirety on the one-year anniversary of the date of grant. Randal J. Kirk controls each of R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), Third Security, LLC ("Third Security"), Parkview 2020 Limited Partnership ("Parkview 2020") and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
FAQ
What insider transaction did Precigen (PGEN) report for Randal J. Kirk?
Precigen reported that director and major shareholder Randal J. Kirk exercised 143,678 restricted stock units into the same number of common shares at $0.00 per share on March 13, 2026, reflecting a vesting-related equity award conversion.
How are Randal J. Kirk’s Precigen holdings structured across entities?
The filing shows shares held indirectly through several entities, including R.J. Kirk DOT, JPK 2008, JPK 2009, JPK 2012, MGK entities, ZSK entities, Kellie L. Banks LTT, Kapital Joe, Lotus, Third Security, Parkview 2020, Sunset 2020 and a spouse account, all controlled by Mr. Kirk.
What does Randal J. Kirk’s beneficial ownership disclaimer mean for Precigen investors?
The disclaimer states that shares held by controlled entities may be deemed beneficially owned by Mr. Kirk, but he disclaims beneficial ownership except for any pecuniary interest. This clarifies his economic stake while noting legal distinctions in ownership across trusts and LLCs.
When were the exercised Precigen restricted stock units originally granted and when did they vest?
The 143,678 restricted stock units were granted on March 13, 2025 and vested in full one year later, on the first anniversary of the grant date. Upon vesting, they converted into an equal number of Precigen common shares reported in this Form 4.